0 XP   0   0   0

Neuroscientific Biopharmaceuticals Ltd










Financial Health of Neuroscientific




Comparing to competitors in the Biotechnology industry




  Industry Rankings  


Neuroscientific Biopharmaceuticals Ltd
Buy, Hold or Sell?

Should you buy, hold or sell Neuroscientific?

I guess you are interested in Neuroscientific Biopharmaceuticals Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Neuroscientific

Let's start. I'm going to help you getting a better view of Neuroscientific Biopharmaceuticals Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Neuroscientific Biopharmaceuticals Ltd even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Neuroscientific Biopharmaceuticals Ltd is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Neuroscientific Biopharmaceuticals Ltd. The closing price on 2022-12-08 was A$0.17 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Neuroscientific Biopharmaceuticals Ltd Daily Candlestick Chart

Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of Neuroscientific Biopharmaceuticals Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Neuroscientific earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Neuroscientific to the Biotechnology industry mean.
  • A Net Profit Margin of -15,644.5% means that $-156.45 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Neuroscientific Biopharmaceuticals Ltd:

  • The MRQ is -15,644.5%. The company is making a huge loss. -2
  • The TTM is -7,643.3%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-15,644.5%TTM-7,643.3%-8,001.3%
TTM-7,643.3%YOY-150.1%-7,493.2%
TTM-7,643.3%5Y-9,877.7%+2,234.4%
5Y-9,877.7%10Y-8,979.7%-898.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-15,644.5%-223.6%-15,420.9%
TTM-7,643.3%-281.7%-7,361.6%
YOY-150.1%-344.8%+194.7%
5Y-9,877.7%-450.1%-9,427.6%
10Y-8,979.7%-541.0%-8,438.7%
1.1.2. Return on Assets

Shows how efficient Neuroscientific is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Neuroscientific to the Biotechnology industry mean.
  • -60.8% Return on Assets means that Neuroscientific generated $-0.61 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Neuroscientific Biopharmaceuticals Ltd:

  • The MRQ is -60.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -40.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-60.8%TTM-40.1%-20.7%
TTM-40.1%YOY-17.9%-22.2%
TTM-40.1%5Y-25.5%-14.6%
5Y-25.5%10Y-23.2%-2.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-60.8%-9.9%-50.9%
TTM-40.1%-8.9%-31.2%
YOY-17.9%-9.3%-8.6%
5Y-25.5%-11.7%-13.8%
10Y-23.2%-12.7%-10.5%
1.1.3. Return on Equity

Shows how efficient Neuroscientific is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Neuroscientific to the Biotechnology industry mean.
  • -85.2% Return on Equity means Neuroscientific generated $-0.85 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Neuroscientific Biopharmaceuticals Ltd:

  • The MRQ is -85.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -46.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-85.2%TTM-46.7%-38.5%
TTM-46.7%YOY-18.4%-28.3%
TTM-46.7%5Y-32.0%-14.7%
5Y-32.0%10Y-29.1%-2.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-85.2%-12.0%-73.2%
TTM-46.7%-11.5%-35.2%
YOY-18.4%-10.8%-7.6%
5Y-32.0%-14.2%-17.8%
10Y-29.1%-15.2%-13.9%

1.2. Operating Efficiency of Neuroscientific Biopharmaceuticals Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Neuroscientific is operating .

  • Measures how much profit Neuroscientific makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Neuroscientific to the Biotechnology industry mean.
  • An Operating Margin of -7,872.3% means the company generated $-78.72  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Neuroscientific Biopharmaceuticals Ltd:

  • The MRQ is -7,872.3%. The company is operating very inefficient. -2
  • The TTM is -3,846.6%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-7,872.3%TTM-3,846.6%-4,025.6%
TTM-3,846.6%YOY-80.1%-3,766.5%
TTM-3,846.6%5Y-1,696.8%-2,149.9%
5Y-1,696.8%10Y-1,542.5%-154.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-7,872.3%-207.3%-7,665.0%
TTM-3,846.6%-271.0%-3,575.6%
YOY-80.1%-325.9%+245.8%
5Y-1,696.8%-454.0%-1,242.8%
10Y-1,542.5%-537.1%-1,005.4%
1.2.2. Operating Ratio

Measures how efficient Neuroscientific is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Neuroscientific Biopharmaceuticals Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y5.906-5.906
5Y5.90610Y5.409+0.497
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.871-2.871
TTM-3.504-3.504
YOY-3.604-3.604
5Y5.9065.132+0.774
10Y5.4096.371-0.962

1.3. Liquidity of Neuroscientific Biopharmaceuticals Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Neuroscientific is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 3.34 means the company has $3.34 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Neuroscientific Biopharmaceuticals Ltd:

  • The MRQ is 3.336. The company is very able to pay all its short-term debts. +2
  • The TTM is 23.855. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.336TTM23.855-20.519
TTM23.855YOY44.799-20.943
TTM23.8555Y48.321-24.466
5Y48.32110Y43.928+4.393
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.3365.117-1.781
TTM23.8555.755+18.100
YOY44.7995.854+38.945
5Y48.3216.511+41.810
10Y43.9286.222+37.706
1.3.2. Quick Ratio

Measures if Neuroscientific is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Neuroscientific to the Biotechnology industry mean.
  • A Quick Ratio of 3.31 means the company can pay off $3.31 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Neuroscientific Biopharmaceuticals Ltd:

  • The MRQ is 3.308. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 11.825. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.308TTM11.825-8.516
TTM11.825YOY22.060-10.236
TTM11.8255Y24.452-12.627
5Y24.45210Y22.309+2.143
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.3084.284-0.976
TTM11.8254.664+7.161
YOY22.0604.787+17.273
5Y24.4525.218+19.234
10Y22.3095.182+17.127

1.4. Solvency of Neuroscientific Biopharmaceuticals Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Neuroscientific assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Neuroscientific to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.29 means that Neuroscientific assets are financed with 28.7% credit (debt) and the remaining percentage (100% - 28.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Neuroscientific Biopharmaceuticals Ltd:

  • The MRQ is 0.287. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.086. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.287TTM0.086+0.200
TTM0.086YOY0.028+0.058
TTM0.0865Y0.096-0.010
5Y0.09610Y0.094+0.002
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2870.278+0.009
TTM0.0860.277-0.191
YOY0.0280.306-0.278
5Y0.0960.367-0.271
10Y0.0940.403-0.309
1.4.2. Debt to Equity Ratio

Measures if Neuroscientific is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Neuroscientific to the Biotechnology industry mean.
  • A Debt to Equity ratio of 40.2% means that company has $0.40 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Neuroscientific Biopharmaceuticals Ltd:

  • The MRQ is 0.402. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.115. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.402TTM0.115+0.286
TTM0.115YOY0.029+0.086
TTM0.1155Y0.180-0.065
5Y0.18010Y0.171+0.009
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4020.315+0.087
TTM0.1150.317-0.202
YOY0.0290.319-0.290
5Y0.1800.403-0.223
10Y0.1710.462-0.291

2. Market Valuation of Neuroscientific Biopharmaceuticals Ltd

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Neuroscientific generates.

  • Above 15 is considered overpriced but always compare Neuroscientific to the Biotechnology industry mean.
  • A PE ratio of -10.98 means the investor is paying $-10.98 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Neuroscientific Biopharmaceuticals Ltd:

  • The EOD is -10.369. Company is losing money. -2
  • The MRQ is -10.979. Company is losing money. -2
  • The TTM is -16.979. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-10.369MRQ-10.979+0.610
MRQ-10.979TTM-16.979+6.000
TTM-16.979YOY-52.017+35.038
TTM-16.9795Y-30.942+13.962
5Y-30.94210Y-28.129-2.813
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-10.369-8.986-1.383
MRQ-10.979-9.792-1.187
TTM-16.979-16.243-0.736
YOY-52.017-20.876-31.141
5Y-30.942-16.665-14.277
10Y-28.129-14.732-13.397

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Neuroscientific is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 4.68 means the investor is paying $4.68 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Neuroscientific Biopharmaceuticals Ltd:

  • The EOD is 4.419. Neutral. Compare to industry.
  • The MRQ is 4.679. Neutral. Compare to industry.
  • The TTM is 4.546. Neutral. Compare to industry.
Trends
Current periodCompared to+/- 
EOD4.419MRQ4.679-0.260
MRQ4.679TTM4.546+0.133
TTM4.546YOY6.809-2.263
TTM4.5465Y4.432+0.114
5Y4.43210Y4.030+0.403
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD4.4191.835+2.584
MRQ4.6792.006+2.673
TTM4.5462.774+1.772
YOY6.8093.453+3.356
5Y4.4322.713+1.719
10Y4.0302.402+1.628
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Neuroscientific Biopharmaceuticals Ltd.


4. Summary

4.1. Key Performance Indicators

The key performance indicators of Neuroscientific Biopharmaceuticals Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.030-0.016-47%0.019-258%0.002-1835%0.002-1824%
Book Value Growth---0.1990.115-274%0.488-141%0.302-166%0.303-166%
Book Value Per Share--0.0380.069-45%0.051-24%0.038+0%0.035+9%
Book Value Per Share Growth---0.783-0.317-60%0.239-428%-0.039-95%-0.037-95%
Current Ratio--3.33623.855-86%44.799-93%48.321-93%43.928-92%
Debt To Asset Ratio--0.2870.086+232%0.028+918%0.096+199%0.094+205%
Debt To Equity Ratio--0.4020.115+248%0.029+1282%0.180+123%0.171+135%
Dividend Per Share----0%-0%-0%-0%
Eps---0.016-0.018+11%-0.006-66%-0.007-57%-0.006-61%
Eps Growth----0.1100%-0.1440%0.018-100%0.018-100%
Gross Profit Margin--1.0001.0000%1.0000%0.950+5%0.864+16%
Net Profit Margin---156.445-76.433-51%-1.501-99%-98.777-37%-89.797-43%
Operating Margin---78.723-38.466-51%-0.801-99%-16.968-78%-15.425-80%
Operating Ratio----0%-0%5.906-100%5.409-100%
Pb Ratio4.419-6%4.6794.546+3%6.809-31%4.432+6%4.030+16%
Pe Ratio-10.369+6%-10.979-16.979+55%-52.017+374%-30.942+182%-28.129+156%
Price Per Share0.170-6%0.1800.314-43%0.278-35%0.190-5%0.173+4%
Price To Total Gains Ratio-5.640+6%-5.972-8.035+35%12.803-147%-914644.687+15316356%-914644.687+15316356%
Profit Growth---66.380-30.776-54%-43.858-34%-38.984-41%-38.984-41%
Quick Ratio--3.30811.825-72%22.060-85%24.452-86%22.309-85%
Return On Assets---0.608-0.401-34%-0.179-71%-0.255-58%-0.232-62%
Return On Equity---0.852-0.467-45%-0.184-78%-0.320-62%-0.291-66%
Revenue Growth--1.0001.0000%1.0000%0.533+88%0.519+93%
Total Gains Per Share---0.030-0.016-47%0.019-258%0.002-1835%0.002-1824%
Total Gains Per Share Growth---1.000-1.0000%1.000-200%-49824.521+4982352%-49824.521+4982352%
Usd Book Value--3711402.5746692415.019-45%4886919.486-24%3699361.571+0%3395814.079+9%
Usd Book Value Change Per Share---0.020-0.011-47%0.013-258%0.001-1835%0.001-1824%
Usd Book Value Per Share--0.0260.047-45%0.034-24%0.026+0%0.024+9%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.011-0.012+11%-0.004-66%-0.005-57%-0.004-61%
Usd Price Per Share0.114-6%0.1210.211-43%0.187-35%0.128-5%0.116+4%
Usd Profit---3163178.044-2631273.503-17%-818891.417-74%-891628.077-72%-810570.979-74%
Usd Revenue--20219.06811508.126+76%175812.428-88%46576.913-57%43504.066-54%
Usd Total Gains Per Share---0.020-0.011-47%0.013-258%0.001-1835%0.001-1824%
 EOD+3 -2MRQTTM+5 -22YOY+2 -265Y+9 -2310Y+9 -23

4.2. Fundamental Score

Let's check the fundamental score of Neuroscientific Biopharmaceuticals Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-10.369
Price to Book Ratio (EOD)Between0-14.419
Net Profit Margin (MRQ)Greater than0-156.445
Operating Margin (MRQ)Greater than0-78.723
Quick Ratio (MRQ)Greater than13.308
Current Ratio (MRQ)Greater than13.336
Debt to Asset Ratio (MRQ)Less than10.287
Debt to Equity Ratio (MRQ)Less than10.402
Return on Equity (MRQ)Greater than0.15-0.852
Return on Assets (MRQ)Greater than0.05-0.608
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Neuroscientific Biopharmaceuticals Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.170
Total0/1 (0.0%)



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in EUR. All numbers in thousands.

Summary
Total Assets7,737
Total Liabilities2,218
Total Stockholder Equity5,520
 As reported
Total Liabilities 2,218
Total Stockholder Equity+ 5,520
Total Assets = 7,737

Assets

Total Assets7,737
Total Current Assets7,398
Long-term Assets7,398
Total Current Assets
Cash And Cash Equivalents 7,216
Net Receivables 121
Other Current Assets 61
Total Current Assets  (as reported)7,398
Total Current Assets  (calculated)7,398
+/-0
Long-term Assets
Property Plant Equipment 17
Intangible Assets 322
Long-term Assets  (as reported)339
Long-term Assets  (calculated)339
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities2,218
Long-term Liabilities0
Total Stockholder Equity5,520
Total Current Liabilities
Accounts payable 2,166
Other Current Liabilities 52
Total Current Liabilities  (as reported)2,218
Total Current Liabilities  (calculated)2,218
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock25,275
Retained Earnings -22,598
Other Stockholders Equity 2,843
Total Stockholder Equity (as reported)5,520
Total Stockholder Equity (calculated)5,520
+/-0
Other
Capital Stock25,275
Cash And Equivalents7,216
Cash and Short Term Investments 7,216
Common Stock Shares Outstanding 143,472
Liabilities and Stockholders Equity 7,737
Net Debt -7,216
Net Invested Capital 5,520
Net Tangible Assets 5,197
Net Working Capital 5,180



Balance Sheet

Currency in EUR. All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-31
> Total Assets 
579
579
495
495
809
809
5,833
5,833
5,123
5,123
4,732
4,732
0
3,738
0
5,617
0
14,827
0
10,063
0
7,737
7,737010,063014,82705,61703,73804,7324,7325,1235,1235,8335,833809809495495579579
   > Total Current Assets 
0
0
0
98
287
287
5,319
5,319
4,637
4,637
4,274
4,274
3,306
3,306
5,192
5,192
14,427
14,427
9,691
9,691
7,398
7,398
7,3987,3989,6919,69114,42714,4275,1925,1923,3063,3064,2744,2744,6374,6375,3195,31928728798000
       Cash And Cash Equivalents 
0
0
0
73
104
104
5,083
5,083
4,610
4,610
4,180
4,180
0
3,287
0
4,988
0
14,162
0
9,499
0
7,216
7,21609,499014,16204,98803,28704,1804,1804,6104,6105,0835,08310410473000
       Net Receivables 
38
38
6
6
20
20
236
236
28
28
62
62
19
19
39
39
49
49
48
48
121
121
1211214848494939391919626228282362362020663838
       Other Current Assets 
0
0
19
19
163
163
0
0
0
0
0
0
0
0
0
0
0
216
0
0
0
61
6100021600000000000163163191900
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
486
0
0
0
432
0
0
0
400
0
0
0
339
339000400000432000486000000000
       Property Plant Equipment 
0
0
0
0
0
0
17
17
14
14
10
10
9
9
27
27
28
28
24
24
17
17
171724242828272799101014141717000000
       Intangible Assets 
415
415
397
397
522
522
497
497
472
472
447
447
0
422
0
397
0
372
0
347
0
322
32203470372039704220447447472472497497522522397397415415
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
486
0
0
0
0
0
0
0
0
0
0
0
0
000000000000486000000000
> Total Liabilities 
43
43
284
284
76
76
28
28
62
62
104
104
0
89
0
208
0
223
0
218
0
2,218
2,21802180223020808901041046262282876762842844343
   > Total Current Liabilities 
43
43
284
284
76
76
28
28
62
62
104
104
89
89
208
208
223
223
218
218
2,218
2,218
2,2182,21821821822322320820889891041046262282876762842844343
       Short-term Debt 
0
0
0
80
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000080000
       Accounts payable 
43
43
29
29
21
21
22
22
43
43
69
69
62
62
159
159
176
176
173
173
2,166
2,166
2,1662,1661731731761761591596262696943432222212129294343
       Other Current Liabilities 
0
0
175
175
55
55
0
0
0
19
0
0
0
27
0
0
0
48
0
0
0
52
52000480002700019000555517517500
   > Long-term Liabilities 0000000000000000000000
> Total Stockholder Equity
536
536
211
211
733
733
5,805
5,805
5,061
5,061
4,628
4,628
0
3,649
0
5,409
0
14,604
0
9,844
0
5,520
5,52009,844014,60405,40903,64904,6284,6285,0615,0615,8055,805733733211211536536
   Retained Earnings -22,598-22,598-17,906-17,906-12,175-12,175-10,264-10,264-9,150-9,150-8,172-8,172-6,282-6,282-4,902-5,464-4,081-4,623-4,013000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
636
0
0
0
1,084
0
0
0
1,505
0
0
0
2,843
2,8430001,5050001,084000636000000000
   Capital Surplus 0000000000000000000000
   Treasury Stock0000000000000000000000



Balance Sheet

Currency in EUR. All numbers in thousands.




Cash Flow

Currency in EUR. All numbers in thousands.




Income Statement

Currency in EUR. All numbers in thousands.


Latest Income Statement (annual, 2022-06-30)

Gross Profit (+$)
totalRevenue68
Cost of Revenue--
Gross Profit-68
 
Operating Income (+$)
Gross Profit-
Operating Expense-10,504
Operating Income-10,504-10,504
 
Operating Expense (+$)
Research Development7,220
Selling General Administrative2,733
Selling And Marketing Expenses-
Operating Expense10,5049,953
 
Net Interest Income (+$)
Interest Income68
Interest Expense-68
Net Interest Income680
 
Pretax Income (+$)
Operating Income-10,504
Net Interest Income68
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-10,435-10,572
EBIT - interestExpense = -10,572
-10,435
-10,367
Interest Expense68
Earnings Before Interest and Taxes (ebit)-10,504-10,367
Earnings Before Interest and Taxes (ebitda)-10,439
 
After tax Income (+$)
Income Before Tax-10,435
Tax Provision-0
Net Income From Continuing Ops-10,435-10,435
Net Income-10,435
Net Income Applicable To Common Shares-10,435
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net68-68
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
YUG.BSE
1 minute ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of YUG.BSE.

YUG.BSE Daily Candlestick Chart
ORIENTCQ.BSE
5 minutes ago

I found you a Death Cross on the daily chart of ORIENTCQ.BSE.

ORIENTCQ.BSE Daily Candlestick Chart
INDSWFTLAB.BSE
6 minutes ago

I found you a Bearish Three Line Strike Candle Pattern on the daily chart of INDSWFTLAB.BSE.

INDSWFTLAB.BSE Daily Candlestick Chart
HARIOMPIPE.BSE
10 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of HARIOMPIPE.BSE.

HARIOMPIPE.BSE Daily Candlestick Chart
GULFPETRO.BSE
10 minutes ago

I found you a Death Cross on the daily chart of GULFPETRO.BSE.

GULFPETRO.BSE Daily Candlestick Chart
DUNCANENG.BSE
12 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of DUNCANENG.BSE.

DUNCANENG.BSE Daily Candlestick Chart
DHARSUGAR.BSE
13 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of DHARSUGAR.BSE.

DHARSUGAR.BSE Daily Candlestick Chart
CENTRALBK.BSE
15 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CENTRALBK.BSE.

CENTRALBK.BSE Daily Candlestick Chart
ARCHITORG.BSE
18 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ARCHITORG.BSE.

ARCHITORG.BSE Daily Candlestick Chart
ADROITINFO.BSE
19 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ADROITINFO.BSE.

ADROITINFO.BSE Daily Candlestick Chart
RACLGEAR.BSE
20 minutes ago

I found you a Golden Cross on the daily chart of RACLGEAR.BSE.

RACLGEAR.BSE Daily Candlestick Chart
QUINT.BSE
20 minutes ago

I found you a Rising Three Methods Candle Pattern on the daily chart of QUINT.BSE.

QUINT.BSE Daily Candlestick Chart
PROFINC.BSE
21 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of PROFINC.BSE.

PROFINC.BSE Daily Candlestick Chart
PPAP.BSE
21 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of PPAP.BSE.

PPAP.BSE Daily Candlestick Chart
OPTIEMUS.BSE
24 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of OPTIEMUS.BSE.

OPTIEMUS.BSE Daily Candlestick Chart
NLCINDIA.BSE
25 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of NLCINDIA.BSE.

NLCINDIA.BSE Daily Candlestick Chart
NITCO.BSE
26 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of NITCO.BSE.

NITCO.BSE Daily Candlestick Chart
ETCC.PINK
28 minutes ago

I found you a Death Cross on the daily chart of ETCC.PINK.

ETCC.PINK Daily Candlestick Chart
RONI.NYSE
29 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of RONI.NYSE.

RONI.NYSE Daily Candlestick Chart
CHNR.NASDAQ
35 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of CHNR.NASDAQ.

CHNR.NASDAQ Daily Candlestick Chart
CHEK.NASDAQ
35 minutes ago

I found you a RSI Bearish Reversal Divergence on the daily chart of CHEK.NASDAQ.

CHEK.NASDAQ Daily Candlestick Chart
CGNT.NASDAQ
36 minutes ago

I found you a Three Black Crows Candle Pattern on the daily chart of CGNT.NASDAQ.

CGNT.NASDAQ Daily Candlestick Chart